tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market

Ionis Pharmaceuticals (IONS) Income Statement

Compare
1,348 Followers

Ionis Pharmaceuticals Income Statement

Last quarter (Q3 2024), Ionis Pharmaceuticals's total revenue was $134.00M, a decrease of -6.94% from the same quarter last year. In Q3, Ionis Pharmaceuticals's net income was $-140.48M. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 787.65M$ 587.00M$ 810.00M$ 729.00M$ 1.12B
Gross Profit
$ 778.51M$ 573.00M$ 799.00M$ 717.00M$ 1.12B
Operating Expenses
$ 1.13B$ 984.00M$ 829.00M$ 889.00M$ 753.00M
Depreciation and Amortization
$ 22.50M$ 22.11M$ 19.56M$ 17.16M$ 15.99M
EBITDA
$ -230.01M$ -227.76M$ -239.00K$ -107.88M$ 411.53M
Operating Income
$ -353.73M$ -411.00M$ -30.00M$ -172.00M$ 366.00M
Other Income/Expenses
$ 19.77M$ 152.21M$ 1.04M$ 37.53M$ -27.12M
Pretax Income
$ -333.96M$ -258.00M$ -30.00M$ -170.00M$ 347.00M
Net Income
$ -366.29M$ -270.00M$ -29.00M$ -487.00M$ 294.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.56$ -1.90$ -0.21$ -3.49$ 2.10
Diluted EPS
$ -2.56$ -1.90$ -0.21$ -3.49$ 2.06
Weighted Average Shares Outstanding
143.00M 141.85M 141.02M 139.61M 140.00M
Weighted Average Shares Outstanding (Diluted)
143.19M 141.85M 141.02M 139.61M 142.87M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis